|
|
|
Volumn 21, Issue 9, 2007, Pages 703-
|
|
48-week data on raltegravir in naive patients.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
MK 0518;
ORGANIC COMPOUND;
UNCLASSIFIED DRUG;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DOUBLE-BLIND METHOD;
HIV INFECTIONS;
HUMANS;
ORGANIC CHEMICALS;
|
|
EID: 70349727457
PISSN: 10872914
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|